Linda J D'Silva1, Patricia M Kluding2, Susan L Whitney3,4, Hongying Dai5, Marcio Santos6. 1. a Department of Physical Therapy and Rehabilitation Science , University of Kansas Medical Center , Kansas City , MO , USA. 2. b Department of Physical Therapy and Rehabilitation Science , University of Kansas Medical Center , Kansas City , MO , USA. 3. c School of Health and Rehabilitation Sciences , University of Pittsburgh , Pittsburgh , PA , USA. 4. d Department of Rehabilitation Sciences , King Saud University , Riyadh , Saudi Arabia. 5. e Health Services and Outcomes Research , Children's Mercy Hospital , Kansas City , MO , USA. 6. f Department of Physical Therapy and Rehabilitation Science , University of Kansas Medical Center , Kansas City , MO , USA.
Abstract
BACKGROUND AND PURPOSE: diabetes has been shown to affect the peripheral vestibular end organs and is associated with an increase in the frequency of benign paroxysmal positional vertigo (BPPV). People with diabetes have higher postural sway; however, the impact of symptomatic BPPV on postural sway in individuals with diabetes is unclear. The purpose of this cross-sectional study was to examine postural sway in people with type 2 diabetes who have symptomatic, untreated BPPV (BPPVDM). METHODS: fifty-two participants (mean age 56.9 ± 5.6 years) were enrolled: controls (n = 14), diabetes (n = 14), BPPV only (n = 13) and BPPVDM (n = 11). An inertial motion sensor was used to detect pelvic acceleration across five standing conditions with eyes open/closed on firm/foam surfaces. Range of acceleration (cm/s2), peak velocity (cm/s) and variability of sway [root mean square (RMS)] in the anterior-posterior (AP) and medial-lateral (ML) directions were used to compare postural sway between groups across conditions. RESULTS: participants with BPPVDM had higher ranges of acceleration in the AP (p = 0.02) and ML (p = 0.02) directions, as well as higher peak velocity (p < 0.001) and RMS values (p = 0.006) in the AP direction compared to the control and diabetes groups. Standing on foam with eyes closed and tandem stance were challenging conditions for people with BPPVDM. CONCLUSION: clinicians may consider using standing on foam with eyes closed and tandem standing with eyes open to assess postural control in people with BPPVDM to identify postural instability.
BACKGROUND AND PURPOSE:diabetes has been shown to affect the peripheral vestibular end organs and is associated with an increase in the frequency of benign paroxysmal positional vertigo (BPPV). People with diabetes have higher postural sway; however, the impact of symptomatic BPPV on postural sway in individuals with diabetes is unclear. The purpose of this cross-sectional study was to examine postural sway in people with type 2 diabetes who have symptomatic, untreated BPPV (BPPVDM). METHODS: fifty-two participants (mean age 56.9 ± 5.6 years) were enrolled: controls (n = 14), diabetes (n = 14), BPPV only (n = 13) and BPPVDM (n = 11). An inertial motion sensor was used to detect pelvic acceleration across five standing conditions with eyes open/closed on firm/foam surfaces. Range of acceleration (cm/s2), peak velocity (cm/s) and variability of sway [root mean square (RMS)] in the anterior-posterior (AP) and medial-lateral (ML) directions were used to compare postural sway between groups across conditions. RESULTS:participants with BPPVDM had higher ranges of acceleration in the AP (p = 0.02) and ML (p = 0.02) directions, as well as higher peak velocity (p < 0.001) and RMS values (p = 0.006) in the AP direction compared to the control and diabetes groups. Standing on foam with eyes closed and tandem stance were challenging conditions for people with BPPVDM. CONCLUSION: clinicians may consider using standing on foam with eyes closed and tandem standing with eyes open to assess postural control in people with BPPVDM to identify postural instability.
Authors: Nancy S Chiles; Caroline L Phillips; Stefano Volpato; Stefania Bandinelli; Luigi Ferrucci; Jack M Guralnik; Kushang V Patel Journal: J Diabetes Complications Date: 2013-10-11 Impact factor: 2.852
Authors: Nicola Napoli; Elsa S Strotmeyer; Kristine E Ensrud; Deborah E Sellmeyer; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Elizabeth Barrett-Connor; Lisa Palermo; Eric S Orwoll; Steven R Cummings; Dennis M Black; Ann V Schwartz Journal: Diabetologia Date: 2014-06-09 Impact factor: 10.122
Authors: Yuri Agrawal; John P Carey; Charles C Della Santina; Michael C Schubert; Lloyd B Minor Journal: Otol Neurotol Date: 2010-12 Impact factor: 2.311
Authors: S L Whitney; J L Roche; G F Marchetti; C-C Lin; D P Steed; G R Furman; M C Musolino; M S Redfern Journal: Gait Posture Date: 2011-02-17 Impact factor: 2.840
Authors: Ann V Schwartz; Eric Vittinghoff; Deborah E Sellmeyer; Kenneth R Feingold; Nathalie de Rekeneire; Elsa S Strotmeyer; Ronald I Shorr; Aaron I Vinik; Michelle C Odden; Seok Won Park; Kimberly A Faulkner; Tamara B Harris Journal: Diabetes Care Date: 2007-12-04 Impact factor: 19.112
Authors: Andrew P Lapointe; Jessica N Ritchie; Rachel V Vitali; Joel S Burma; Ateyeh Soroush; Ibukunoluwa Oni; Jeff F Dunn Journal: Sensors (Basel) Date: 2021-06-30 Impact factor: 3.576